In diabetic kidneys, myeloid MR deficiency reduced renal dysfunction (elevated plasma cystatin C) but did not protect against albuminuria, glomerulosclerosis or tubular damage; this was associated with a partial reduction in glomerular macrophages and an M1 to M2 macrophage phenotype switch. The gene discussed is CST3; the disease is glomerulosclerosis.